RecruitingNot ApplicableNCT06190717

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial


Sponsor

Sonavex, Inc.

Enrollment

304 participants

Start Date

Feb 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.


Eligibility

Min Age: 18 YearsMax Age: 84 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new automated ultrasound monitoring system to track the development and readiness of an arteriovenous fistula — a surgically created connection between an artery and vein in the arm used for kidney dialysis. **You may be eligible if...** - You are between 18 and 85 years old - You have advanced kidney failure (stage 5, eGFR below 10) or are already on dialysis through a central venous catheter - You are scheduled to have an upper arm fistula created for dialysis access - Your veins and arteries are large enough for surgery (≥2.5 mm diameter) - Your estimated life expectancy is greater than 18 months **You may NOT be eligible if...** - You have had three or more failed fistulas previously - You are immunocompromised or immunosuppressed - You have a history of vascular steal syndrome in the arm - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEchoMark/EchoSure

Subjects assigned to the Diagnostic Arm will have the EchoMark implanted at the time of AVF creation. The subject will return every 2 weeks for a follow-up assessment to include an EchoSure scan until fistula maturation and/or permanent access use is achieved. The EchoSure scans are to be reviewed by the investigator(s) or delegated study staff and aid in the determination when a further assessment, including a physical exam, is required to determine cannulation clearance or if an intervention(s) may be required to prevent failure of fistula maturation. All physical exams will include assessing the fistula for bruit and thrill. The subject's medical history will be reviewed at each visit and will include all interventions, cannulation attempts, and adverse event reporting.

PROCEDUREStandard of Care

Subjects are assessed using standard of care per KDOQI guidelines, which includes a physical exam at the 2-week follow-up visit and at the 4-6-week follow-up visit. All follow-up visits will include an assessment of adverse events and medical history review to include all interventions, cannulation attempts, and laboratory results. If evaluation yields an abnormal finding, subjects will undergo a Duplex ultrasound assessment and treatment under the institution's standard of care. All SOC Arm subjects will be followed per the institution's standard of care until fistula maturation occurs and/or permanent access use is achieved but no more frequently than once per month.


Locations(21)

Trinity Research Group

Dothan, Alabama, United States

Southwest Kidney Institute

Phoenix, Arizona, United States

AKDHC Medical Research Services

Phoenix, Arizona, United States

AKDHC Center Tucson

Tucson, Arizona, United States

Orlando Health Heart and Vascular Institute

Orlando, Florida, United States

Northwestern University

Chicago, Illinois, United States

Kansas Nephrology Research Institute

Wichita, Kansas, United States

Boston Medical Center

Boston, Massachusetts, United States

MSU Health Care Heart and Vascular

Lansing, Michigan, United States

Capital Medical Center

Pennington, New Jersey, United States

Northwell Health

New Hyde Park, New York, United States

Atrium Health

Concord, North Carolina, United States

Prisma Health

Greenville, South Carolina, United States

Medical University of South Carolina Health Orangeburg

Orangeburg, South Carolina, United States

Galen Medical Group

Chattanooga, Tennessee, United States

Fresenius Vascular Care Memphis MSO

Memphis, Tennessee, United States

Baylor Scott & White Heart and Vascular Hospital

Dallas, Texas, United States

Aqua Research Institute Llc

Houston, Texas, United States

HealthQare Associates

Arlington, Virginia, United States

Physicians Care of Virginia

Roanoke, Virginia, United States

Sentara Health

Virginia Beach, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06190717


Related Trials